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An important task in the life of bacteria
is to influence their environment, which
for commensal, symbiotic, and pathogenic
bacteria also includes their hosts. This is
done primarily by secreting various sets of
proteins (effectors), either simply to the
outside environment or directly into host
cells. This task is performed by specialized
secretion systems that are complex, multi-
protein molecular machines. While some
of these systems are conserved across all
domains of life, Gram-negative bacteria,
with their two-layered membranes, face
additional challenges and developed at
least six different secretion systems. One of
the best characterized systems is the type
III secretion system (T3SS), discovered in
1994 by Rosqvist and colleagues in Yersinia
[1]. It closely resembles and shares multi-
ple elements with the flagellar apparatus,
from which it probably evolved. We
mostly associate this system with disease,
such as plague, enterocolitis, whooping
cough, pneumonia, and many other dis-
eases that result from infections by Gram-
negative species of Yersinia, Salmonella,
Shigella, Bordetella, Pseudomonas, and other
species, all of which use the T3SS. While
secretion systems provide the means for
invasion, the actual work is performed by
the secreted proteins, or the effectors. To
be successful, the right set of effectors must
be expressed and bacteria must have a
way to control which of the many proteins
in the cytosol are being exported. In many
secretion systems, this control is performed
by specific signals on secreted proteins,
usually the N-terminal signaling peptides
that are recognized by the specialized
components of the secretion system. Such
a segregation may not only help in the
secretion process, but may also ensure that
only the actual effectors are secreted. In
this context, the T3SS appeared to be
somewhat of a puzzle, as T3SS effectors
share no apparent common features. In
many cases, close homologs of effector
proteins of one species are not secreted in
others. This has even led some to argue
that the T3SS acts randomly, secreting
proteins based on their abundance and
proximity to the secretion apparatus. The
question of identifying features of T3SS
effectors is very important and goes
beyond our fundamental interest in how
such a system works. For many important
pathogens we have not yet identified all
T3SS effectors, making it possible that
some important virulence factors, perhaps
common to different diseases, are still
unknown. For many less studied species
we simply know nothing about possible
effectors.
In this issue of PLoS Pathogens, two teams
change this situation, presenting a novel
methodology to recognize unknown effec-
tors of the T3SS [2,3]. Both groups used
the advanced machine learning approach
to identify a universal T3SS effector
signature. The major breakthrough in
both approaches was the use of machine
learning algorithms able to recognize
features that go beyond simple amino acid
patterns and/or hydrophobicity profiles.
Both approaches result in easy to use
prediction algorithms and both groups
predict scores of previously unknown
(putative!) substrates of the T3SS; interest-
ingly, they also predict substrates in species
previously not studied for the presence of
T3SS effectors, e.g., Deinococci or the
pathogen Chlamydia trachomatis. In a fasci-
nating sign of times, data analysis and
verifiable predictions precede experimen-
tal work on many of the new systems,
providing experimental groups in this field
with both a challenge and a series of
specific hypotheses and predictions.
Interestingly, many newly predicted
effectors have no function assigned, sug-
gesting that new classes of virulence factors
may still remain to be characterized.
Another intriguing question concerning
the newly discovered effector signatures is
where does such a generality come from?
Arnold and colleagues [2] suggest that it is
caused by convergent sequence adaptation
of the signal peptide under the selective
pressure rewarding the bacteria for opti-
mizing their set of effectors. On the other
hand, in a 2006 PLoS Pathogens article,
Stavrinides and colleagues proposed a
shuffling process of N-termini, coining a
new term, ‘‘terminal reassortment’’ [4].
Arnold et al. advocate a syncretist model
with both mechanisms acting at the same
time. Last, but not least, recognition of
common effector signatures suggests the
existence of an as yet uncharacterized
mechanism of effector recognition by the
T3SS system. As with all good research,
both papers, while answering some ques-
tions, raise many others and highlight new
puzzles concerning the T3SS, as well as
disease mechanisms of new and old
pathogens.
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